21 resultados para Exames médicos
Resumo:
A informação inerente aos medicamentos no processo de medicação e prescrição tem revelado insuficiências relativamente às necessidades do utilizador. Este projecto aborda essas dificuldades e procura contribuir, através do design e avaliação de pictogramas farmacêuticos, para um melhor acesso das pessoas à informação, oral e escrita, prestada por médicos, farmacêuticos e pela literatura inclusa dos medicamentos. Verificámos que, nos últimos 40 anos, se desenvolveram quase mil representações gráficas, provenientes de 20 países, sobre mensagens relativas a perigos, precauções e informações de como tomar o medicamento. Com base nesse conjunto mundial colectado, tão alargado e diversificado, procedeu-se à analise, agrupamento e comparação dessas representações com vista a apurar a diversidade gráfica e escrita das 75 mensagens farmacêuticas identificadas nesta investigação. Foi seguidamente consultada uma centena de profissionais de saúde dentro da área farmacêutica para selecção e definição da informação a ser projectada em pictogramas. Algumas das mensagens seleccionadas foram, por ordem de importância: “Não aplicar nos olhos”, “Não beber álcool enquanto estiver a tomar o medicamento” e “Guardar no frigorífico”. Foi concebido um sistema PictoPharma, bilingue (Português e Inglês), composto por 32 pictogramas farmacêuticos, com várias possibilidades cromáticas de acordo com as diversas aplicações para suportes de impressão e ecrã (Registo de Propriedade Industrial – marca e design). Embora o sistema projectado possa aumentar a capacidade de recordar as informações importantes pelas pessoas em geral, os públicos-alvo que mais beneficiarão com o sistema são: pessoas que apresentam especiais dificuldades de leitura - analfabetos, pessoas com nenhum conhecimento ou um conhecimento limitado da língua; pessoas com dificuldades para relembrar e / ou compreender o tratamento - população envelhecida, sob múltiplos tratamentos ou com menores capacidades intelectuais; pessoas que não falam a língua local ou são de uma cultura diferente - estrangeiros, turistas, imigrantes. Foram feitos testes de usabilidade com os públicos-alvo específicos, de forma a verificar a percentagem de compreensão dos pictogramas, sem a respectiva legenda e de acordo com as normas internacionais de normalização. Os resultados dos testes indicaram que metade do sistema atingiu os 100% de compreensão e a outra metade atingiu mais de 88%. O sistema PictoPharma criado caracteriza-se: pelo design gráfico no seu contraste visual e na possibilidade de leitura numa escala reduzida; pelo conceito de familiaridade gráfica representada no seu conjunto, de forma a tornar os pictogramas mais facilmente memorizáveis; pelo estudo feito para minimizar especificidades culturais visuais; pelas diversas aplicações possíveis na indústria; pelas direcções que aponta para futuras investigações sobre as escolhas visuais culturais inerentes a um projecto de design com este.
Resumo:
Silver nanoparticles (AgNP) have been produced and applied in a variety of products ranging from personal care products to food package containers, clothing and medicine utilities. The antimicrobial function of AgNP makes it very useful to be applied for such purposes. Silver (Ag) is a non-essential metal for organisms, and it has been historically present in the environment at low concentrations. Those concentrations of silver increased in the last century due to the use of Ag in the photographic industry and lately are expected to increase due to the use of AgNPs in consumer products. The presence of AgNP in the aquatic environment may pose a risk for aquatic species, and the effects can vary from lethal to sublethal effects. Moreover, the contact of aquatic organisms with AgNP may not cause immediately the death of individuals but it can be accumulated inside the animals and consequently transferred within the food chain. Considering this, the objective of this work was to study the transfer of silver nanoparticles in comparison to silver ions, which was used as silver nitrate, within an aquatic food chain model. To achieve this goal, this study was divided into four steps: the toxicity assessment of AgNP and AgNO3 to aquatic test-species, the bioaccumulation assessment of AgNP and AgNO3 by Pseudokirchneriella subcapitata and Daphnia magna under different exposure scenarios, and finally the evaluation of the trophic transfer of Ag through an experimental design that included the goldfish Carassius auratus in a model trophic chain in which all the species were exposed to the worse-case scenario. We observed that the bioconcentration of Ag by P. subcapitata is mainly driven by ionic silver, and that algae cannot internalize these AgNPs, but it does internalizes dissolved Ag. Daphnia magna was exposed to AgNP and AgNO3 through different exposure routes: water, food and both water and food. The worse-case scenario for Daphnia Ag bioaccumulation was by the joint exposure of contaminated water and food, showing that Ag body burdens were higher for AgNPs than for AgNO3. Finally, by exposing C. auratus for 10 days through contaminated water and food (supplied as D. magna), with another 7 days of depuration phase, it was concluded that the 10 days of exposure were not enough for fish to reach a plateau on Ag internal concentration, and neither the 7 days of elimination were sufficient to cause total depuration of the accumulated Ag. Moreover, a higher concentration of Ag was found in the intestine of fish when compared with other organs, and the elimination rate constant of AgNP in the intestine was very low. Although a potential for trophic transfer of AgNP cannot be suggested based in the data acquired in this study, there is still a potential environmental risk for aquatic species.
Resumo:
The development of computed tomography systems with energy resolving detectors is a current challenge in medical physics and biomedical engineering. A computed tomography system of this kind allows getting complementary informations relatively to conventional systems, that can help the medical diagnosis, being of great interest in medicine. The work described in this thesis is related to the development of a computed tomography system using micropattern gaseous detectors, which allow storing, simultaneously, information about the interaction position and the energy of each single photon that interacts with the detector. This kind of detectors has other advantages concerning the cost and characteristics of operation when compared with solid state detectors. Tomographic acquisitions were performed using a MicroHole & Strip Plate based detector, which allowed reconstructing cross-sectional images using energy windows, applying the energy weighting technique and performing multi-slice and tri-dimensional reconstructions. The contrast-to-noise ratio was improved by 31% by applying the energy weighting technique, comparing with the corresponding image obtained with the current medical systems. A prototype of a computed tomography with flexibility to change the detector was developed, making it possible to apply different detectors based on Thick-COBRA. Several images acquired with these detectors are presented and demonstrate their applicability in X-ray imaging. When operating in NeCH4, the detector allowed a charge gain of 8 104, an energy resolution of 20% (full width at half maximum at 8 keV), a count rate of 1 106 Hz/mm2, a very stable operation (gain fluctuations below 5%) and a spacial resolution of 1.2 mm for an energy photon of 3.6 keV. Operating the detector in pure Kr allowed increasing the detection efficiency and achieving a charge gain of 2 104, an energy resolution of 32% (full width at half maximum at 22 keV), a count rate of 1 105 Hz/mm2, very stable operation and a spatial resolution of 500 m. The software already existing in the group was improved and tools to correct geometric misalignments of the system were also developed. The reconstructions obtained after geometrical correction are free of artefacts due to the referred misalignments.
Resumo:
Enquadramento: O ‘Physiosensing’ (‘PhyS’) é um dispositivo médico destinado ao treino do controlo postural nas posições de sentado e de pé, bem como no levantar e sentar, possibilitando também a avaliação do desempenho a este nível. Este trabalho teve como objetivo avaliar a fiabilidade e a validade da plataforma ‘Physiosensing’ na avaliação do equilíbrio em pessoas com deficiência intelectual (PCDI). Métodos: Para o grupo experimental (GE) foram recrutados 47 indivíduos com deficiência intelectual e para o grupo de controlo (GC) 39 indivíduos sem deficiência intelectual, provenientes da região do BaixoMondego. A avaliação da fiabilidade incluiu as análises da concordância entre observadores, reprodutibilidade temporal e consistência interna. A análise fatorial exploratória analisou os pressupostos de subdomínios propostos pelos autores. A validade discriminante foi analisada através da comparação de resultados entre o GE e o GC, e a validade concorrente pela análise dos valores de associação entre os resultados do ‘PhyS’ com a Escala de Equilíbrio de Berg (EEB). Resultados: O subconjunto de exercícios relacionados com a transferência de peso lateralmente (TPL) apresentou os resultados mais elevados a nível da concordância entre observadores (0,40 ≤ CCI > 0,75) e na reprodutibilidade intemporal (CCI ≥ 0,75). O instrumento apresenta uma consistência interna fraca (α = 0,63) quando considerados todos os exercícios, tendo-se obtido o melhor resultado para o subconjunto de exercícios TPL (α = 0,81). A análise fatorial exploratória devolveu quatro fatores, explicando 76,4% da variância, agrupando no primeiro fator o subconjunto de exercícios TPL. Foram encontradas diferenças estatisticamente significativas entre os resultados dos participantes com e sem deficiência intelectual, em dez dos onze exercícios que compõem a configuração da plataforma. Seis exercícios, que incluem os exercícios TPL, apresentam valores de associação estatisticamente significativos com a EEB. Conclusão: Alguns exercícios da plataforma ‘PhyS’ não se mostram adequados para medir o equilíbrio em PCDI, não podendo ser incluídos numa medida global. No entanto, os exercícios TPL poderão constituir um indicador global do equilíbrio em pessoas com PCDI. Recomenda-se a definição de procedimentos de medição de forma a melhorar os índices de fiabilidade, o aprofundamento da configuração de exercícios para a avaliação do equilíbrio e o estudo do potencial da plataforma em programas de intervenção para o treino das funções do equilíbrio.
Resumo:
According to the World Health Organization, around 8.2 million people die each year with cancer. Most patients do not perform routine diagnoses and the symptoms, in most situations, occur when the patient is already at an advanced stage of the disease, consequently resulting in a high cancer mortality. Currently, prostate cancer is the second leading cause of death among males worldwide. In Portugal, this is the most diagnosed type of cancer and the third that causes more deaths. Taking into account that there is no cure for advanced stages of prostate cancer, the main strategy comprises an early diagnosis to increase the successful rate of the treatment. The prostate specific antigen (PSA) is an important biomarker of prostate cancer that can be detected in biological fluids, including blood, urine and semen. However, the commercial kits available are addressed for blood samples and the commonly used analytical methods for their detection and quantification requires specialized staff, specific equipment and extensive sample processing, resulting in an expensive process. Thus, the aim of this MSc thesis consisted on the development of a simple, efficient and less expensive method for the extraction and concentration of PSA from urine samples using aqueous biphasic systems (ABS) composed of ionic liquids. Initially, the phase diagrams of a set of aqueous biphasic systems composed of an organic salt and ionic liquids were determined. Then, their ability to extract PSA was ascertained. The obtained results reveal that in the tested systems the prostate specific antigen is completely extracted to the ionic-liquid-rich phase in a single step. Subsequently, the applicability of the investigated ABS for the concentration of PSA was addressed, either from aqueous solutions or urine samples. The low concentration of this biomarker in urine (clinically significant below 150 ng/mL) usually hinders its detection by conventional analytical techniques. The obtained results showed that it is possible to extract and concentrate PSA, up to 250 times in a single-step, so that it can be identified and quantified using less expensive techniques.
Resumo:
According to the World Health Organization, around 8.2 million people die each year with cancer. Most patients do not perform routine diagnoses and the symptoms, in most situations, occur when the patient is already at an advanced stage of the disease, consequently resulting in a high cancer mortality. Currently, prostate cancer is the second leading cause of death among males worldwide. In Portugal, this is the most diagnosed type of cancer and the third that causes more deaths. Taking into account that there is no cure for advanced stages of prostate cancer, the main strategy comprises an early diagnosis to increase the successful rate of the treatment. The prostate specific antigen (PSA) is an important biomarker of prostate cancer that can be detected in biological fluids, including blood, urine and semen. However, the commercial kits available are addressed for blood samples and the commonly used analytical methods for their detection and quantification requires specialized staff, specific equipment and extensive sample processing, resulting in an expensive process. Thus, the aim of this MSc thesis consisted on the development of a simple, efficient and less expensive method for the extraction and concentration of PSA from urine samples using aqueous biphasic systems (ABS) composed of ionic liquids. Initially, the phase diagrams of a set of aqueous biphasic systems composed of an organic salt and ionic liquids were determined. Then, their ability to extract PSA was ascertained. The obtained results reveal that in the tested systems the prostate specific antigen is completely extracted to the ionic-liquid-rich phase in a single step. Subsequently, the applicability of the investigated ABS for the concentration of PSA was addressed, either from aqueous solutions or urine samples. The low concentration of this biomarker in urine (clinically significant below 150 ng/mL) usually hinders its detection by conventional analytical techniques. The obtained results showed that it is possible to extract and concentrate PSA, up to 250 times in a single-step, so that it can be identified and quantified using less expensive techniques.